[1]
Albrecht, J.D. et al. 2022. Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects. Acta Dermato-Venereologica. 102, (May 2022), adv00722. DOI:https://doi.org/10.2340/actadv.v102.2487.